Mga Industriya

• Reset all ×
• Pangangalaga sa Kalusugan & Mga Agham sa Buhay ×
• Tsina ×

Showing 31–40 ng mga 44 results

Sort by popularity Sort by average rating Sort by latest Sort by price: low to high Sort by price: high to low

• 

  Bladder Cancer Market in China

  Ayon sa StrategyHelix, the bladder cancer market in China, sa dami ng mga tuntunin, is expected to expand at a CAGR of 3.1% sa panahon ng pagsusuri ng 2021 sa 2027.

  USD 5
• 

  Pancreatic Cancer Market in China

  According to a statistic by StrategyHelix, the pancreatic cancer market in China, sa dami ng mga tuntunin, is expected to expand at a CAGR of 3.3% sa panahon ng pagtataya (2021-2027).

  USD 5
• 

  Lymphoma Market in China

  Ayon sa StrategyHelix, the lymphoma market in China, sa dami ng mga tuntunin, is expected to expand at a CAGR of 2.3% sa susunod na limang taon.

  USD 10
• 

  Urothelial Cancer Market in China

  According to a statistic by StrategyHelix, the urothelial cancer market in China, sa dami ng mga tuntunin, is expected to expand at a CAGR of 3.2% mula sa 2021 sa pamamagitan ng 2027.

  USD 5
• 

  Gastric Cancer Market in China

  The gastric cancer market in China was estimated at 470 libong units sa 2020 and is anticipated to reach 579 thousand units by 2027, umuusad sa isang CAGR ng 3% throughout the forecast period, ayon sa StrategyHelix.

  USD 10
• 

  Breast Cancer Market in China

  Ayon sa StrategyHelix, the breast cancer market in China, sa dami ng mga tuntunin, is expected to expand at a CAGR of 1.2% mula sa 2021 sa pamamagitan ng 2027.

  USD 5
• 

  Non-small-cell Lung Carcinoma (NSCLC) Market in China

  At 3% CAGR, the non-small-cell lung carcinoma (NSCLC) market in China is projected to reach 967 thousand units by 2027, ayon sa data at analytics company na StrategyHelix.

  USD 10
• 

  Nasopharyngeal Cancer Market in China

  According to a statistic by StrategyHelix, the nasopharyngeal cancer market in China, sa dami ng mga tuntunin, is expected to expand at a CAGR of 1.2% sa susunod na limang taon.

  USD 5
• 

  Head and Neck Cancer Market in China

  The head and neck cancer market in China, sa dami ng mga tuntunin, is expected to expand at a CAGR of 1.7% mula sa 2021 sa pamamagitan ng 2027, ayon sa data at analytics company na StrategyHelix.

  USD 5
• 

  Oncology Drug Market in China

  The oncology drug market in China is poised to grow at a CAGR of around 13.3% sa panahon ng pagsusuri ng 2021 sa 2027, ayon sa data at analytics company na StrategyHelix.

  USD 10